OR WAIT null SECS
© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
December 07, 2021
“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
November 29, 2021
“There really shouldn't be a stigma about robotic surgery. I think that we should embrace this technology that has really revolutionized the way that we do surgery,” says Michael A. Palese, MD.
November 22, 2021
“All of human health is inextricably linked with environmental health,” says Stacy Loeb, MD, PhD, MSc.
November 10, 2021
“[Promoting anti-microbial resistance is] really the only stigma and it's not the fault of the patients with recurrent urinary tract infection…most of us in the medical profession realize that this stigma is more the result of our only treatment we have for this condition,” says J. Curtis Nickel, MD, FRCSC.
November 01, 2021
“I wouldn't be surprised if we have spotty distribution areas of concern for the next several years,” says Sam S. Chang MD, MBA, on the latest episode of the UT podcast Speaking of Urology.
October 18, 2021
“That's certainly the most significant stigma, the stigma that you're not quite the man that you want to be or what you perceive your partner wants you to be,” says Arthur L. Burnett, MD, MBA, FACS.
September 29, 2021
“As health care professionals, we've got…an incredibly important role and responsibility with regards to increasing awareness and education, and then really trying to address the barriers and bring down the barriers,” says Jai Seth, MD.
September 27, 2021
“Our study strongly suggests that telemedicine can become the mainstay of treatment within FPMRS even after the COVID-19 pandemic has ended,” says Christina Shin, BA.
September 24, 2021
“Opioids are opioids…they can lead to long-term usage regardless of their FDA class. We really need to be good stewards for our patients,” says Sarah F. Faris, MD.
September 21, 2021
“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.